Navigation Links
Elekta to Demonstrate Latest MOSAIQ OIS Innovations for Oncology Practices at 2012 ASCO Annual Meeting
Date:5/30/2012

ATLANTA, May 30, 2012 /PRNewswire/ -- Advanced automation, sophisticated eScribe merge field capabilities and an American Cancer Society clinician portal are among the new innovations showcased in Elekta's MOSAIQ® Oncology Information System (OIS)  at the American Society of Clinical Oncology (ASCO) Annual Meeting, June 1-4, at McCormick Place in Chicago.

In addition, for the sixth consecutive year, Elekta (booth #4019) has been selected to demonstrate at ASCO's EHR Vendor Lab. The 2012 Lab will be a live, in-person resource held June 2-4 in the Oncology Professionals Hall, booth #5004.

MOSAIQ is designed to manage the complete spectrum of oncology treatments in a single patient record. For chemotherapy, MOSAIQ provides a clear, flexible way to chart the patient's treatment across the medical assessment and chemotherapy administration process.

New in MOSAIQ:

  • Clinicians can bring advanced automation to the oncology practice through MOSAIQ IQ Scripts, a tool that launches a customizable "script" of activities that connect to each other. For example, IQ Scripts might be used to generate a warning message or launch an assessment based on order approval or Quality Checklist (QCL) completion. The results are exceptional control, efficiency and customization across the entire oncology workflow.
  • Enhancements to eScribe Merge Fields are available, allowing the user to put clinical, insurance, and scheduling information about the patient in eScribe documents, including the ability to add new fields instantly from a new drag-and-drop interface.
  • Oncologists will be able to launch the American Cancer Society's Clinician Portal directly from MOSAIQ, allowing instant access to their library of patient resources.
  • Full featured and integrated Survivorship module, allowing physicians to create a patient-specific treatment summary with recommendations for treatment follow up, including support resources in the community, treatment summary and recommendations for follow-up care.

MOSAIQ is the first comprehensive, oncology-specific EMR certified for meaningful use under the federal government's American Recovery and Reinvestment Act. The latest version of MOSAIQ is optimized for practices planning to demonstrate meaningful use, which qualifies them to receive payments from the Centers for Medicare & Medicaid Services (CMS) under Medicare rules.

MOSAIQ ranked first in the 2011 Best in KLAS Awards: Software & Services report. KLAS's data also are supported by the U.S. News & World Report 2011-12 best hospital rankings, which indicate that 46 out of the 50 top-ranked cancer hospitals are users of Elekta's oncology software.

"Yearly, ASCO always attracts the top minds in oncology, and we're honored to support this event," says Todd Powell, Executive Vice President, Elekta Software. "We anticipate that visitors to the Elekta exhibit will see once again why MOSAIQ is the preferred OIS for thousands of oncology practices."

Learn more at www.elekta.com/mosaiq.

For further information, please contact:
Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37, email: stina.thorman@elekta.com
Time zone: CET: Central European Time

Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: michelle.joiner@elekta.com
Time zone: ET: Eastern Time

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.


'/>"/>
SOURCE Elekta
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Elekta Announces Clinical Start-Up of New Leksell Gamma Knife(R) Perfexion(TM) at UPMC
2. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
3. First Clinical Volumetric Modulated Arc Therapy Treatment Completed With Elekta Synergy(R) S at General Hospital Vienna
4. Elektas New Line of Stereotactic Treatment Solutions is Redefining Excellence in Stereotaxy, a Case at a Time
5. Seattles Swedish Cancer Institute First in U.S. to Treat Cancer Patient with Elekta VMAT
6. CMS, Inc., an Elekta Company, Announces First Cancer Patients Treated With Monaco(TM) Radiation Treatment Planning System
7. Massachusetts General Hospital Selects Elekta As New Vendor for Complete Cancer Treatment Solution
8. National Intrepid Center of Excellence To Combat Traumatic Brain Injury With Sophisticated Brain Mapping Technology From Elekta
9. Elekta Provides Complete Planning, Treatment and Workflow Solution for Roy and Patricia Disney Family Cancer Center
10. Elekta Demonstrates Continued Leadership in Image Guidance at 2009 ASTRO Annual Meeting
11. Elekta Expands Consultative Services Program to Help MOSAIQ Customers Demonstrate Meaningful Use Guidelines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... janvier 2017  ResMed (NYSE : RMD), BMC (Pékin, Chine) ... annoncé aujourd,hui qu,ils se sont mis d,accord sur le ... parties. BMC et 3B seront autorisés à vendre leurs ... ResMed, et ResMed effectuera le paiement de la décision ... litige de Floride entre les deux parties. Le règlement ...
(Date:1/23/2017)... 2017 NeuroVive Pharmaceutical AB (Nasdaq Stockholm: ... preclinical collaboration agreement with the Children,s Hospital of ... M.D., a US key opinion leader in the mitochondrial medicine ... ... from NeuroVive,s research program, NVP015, in certain experimental disease models. ...
(Date:1/22/2017)... DAVOS, Switzerland and ABU DHABI , ... leaders from the US ... , Hospital of the Future , at ... in the hospital of the future will be driven by big data and ... better," according to the panel of experts that discussed the ,Hospital of the ...
Breaking Medicine Technology:
(Date:1/23/2017)... ... January 23, 2017 , ... "ProRandom is a set of camera tools that allow video ... in Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... of text with video footage. ProRandom works by using a virtual camera to create ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... Society of Anesthesiologists® (ASA®), the Foundation for Anesthesia Education and Research (FAER), ... (AAOS) and the Cigna Foundation, encourages proposals supporting high quality research using ...
(Date:1/23/2017)... ... ... a story of love and redemption, hope and uncertainty as a girl makes her way ... at the Mill” is the creation of published author, Lois Kulp, who was born in ... County on Crow Hill. The inn, the mill and "Post Yokel" are within ...
(Date:1/23/2017)... , ... January 23, 2017 ... ... (SNP) has launched online education programs and resources at seafoodnutrition.org/programs and seafoodnutrition.org/resources ... benefits of a seafood-rich diet. These resources have been developed for use ...
(Date:1/23/2017)... ... ... “Some Infallible Characteristics of Christ”: a fascinating and entrancing novel exploring the gifts ... published author, Rev. Dr. Robert W. Thomas, the third of seven siblings. He was ... a pastor for over fifteen years. He is a graduate of N.C. College of ...
Breaking Medicine News(10 mins):